Minerva Neurosciences

Minerva Neurosciences Dividend Coverage

Dividend Coverage Ratio of Minerva Neurosciences (NERV) as of Nov 5, 2026.

Dividend Coverage

-

Last updated:

Dividend Coverage Ratio of Minerva Neurosciences is 2026 - . Dividend Coverage Ratio of Minerva Neurosciences was 2025 - . It decreases by % lower compared to the previous year.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Minerva Neurosciences Stock analysis

What does Minerva Neurosciences do? Minerva Neurosciences Inc, based in Waltham, US, is a clinical-stage biopharmaceutical company focused on developing treatments for central nervous system diseases. The company, listed in 2014, operates with a portfolio including MIN-101 for schizophrenia, MIN-202 for insomnia and depression, MIN-117 for depression, and MIN-301 for Parkinson's disease. It employs seven full-time staff and targets neurological conditions through innovative biotechnology approaches. Minerva Neurosciences is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Minerva Neurosciences stock

On Eulerpool you can find the complete historical development of Dividend Coverage Ratio Minerva Neurosciences since 2006 – with annual values, charts, and detailed analysis.

The dividend coverage ratio measures how many times dividends can be covered by net income. Higher coverage suggests more sustainable dividend payments.

Dividend Coverage Ratio's is a key factor for investors. Changes in this metric can signal improving or deteriorating fundamentals, directly impacting the stock price. On Eulerpool, you can track Dividend Coverage Ratio's Minerva Neurosciences historically and in real time.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Dividend — Minerva Neurosciences

All Key Metrics — Minerva Neurosciences